Clinical trial
A Prospective, Multi-Center, Pilot Study to Compare the Safety and Effectiveness of WATCHMAN Left Atrial Appendage Occlusion Device With Rivaroxaban for Stroke Prevention in Patients With Atrial Fibrillation
NCT02549963 is registered in ClinicalTrials.gov with Shulin Wu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Center, Pilot Study to Compare the Safety and Effectiveness of WATCHMAN Left Atrial Appendage Occlusion Device With Rivaroxaban for Stroke Prevention in Patients With Atrial Fibrillation
- Lead sponsor
- Shulin Wu
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- Not reported
- Enrollment
- 200 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.